Disentangling biologically distinct subgroups of Alzheimer's disease (AD) may facilitate a deeper understanding of the neurobiology underlying clinical heterogeneity. We employed longitudinal [18F]FDG-PET standardized uptake value ratios (SUVRs) to map hypometabolism across cognitively-defined AD subgroups. Participants were 384 amyloid-positive individuals with an AD dementia diagnosis from ADNI who had a total of 1028 FDG-scans (mean time between first and last scan: 1.6 ± 1.8 years). These participants were categorized into subgroups on the basis of substantial impairment at time of dementia diagnosis in a specific cognitive domain relative to the average across domains. This approach resulted in groups of AD-Memory (n = 135), AD-Executi...
Background: We previously found temporoparietal-predominant atrophy patterns in the behavioral varia...
Background: We previously found temporoparietal-predominant atrophy patterns in the behavioral varia...
Understanding Alzheimer’s disease (AD) heterogeneity is important for understanding the underlying p...
Disentangling biologically distinct subgroups of Alzheimer's disease (AD) may facilitate a deeper un...
Disentangling biologically distinct subgroups of Alzheimer's disease (AD) may facilitate a deeper un...
Disentangling biologically distinct subgroups of Alzheimer’s disease (AD) may facilitate a deeper un...
Disentangling biologically distinct subgroups of Alzheimer’s disease (AD) may facilitate a deeper un...
Disentangling biologically distinct subgroups of Alzheimer's disease (AD) may facilitate a deeper un...
In PET studies of patients with Alzheimer disease (AD), prominent hypometabolism can occur in brain ...
In PET studies of patients with Alzheimer disease (AD), prominent hypometabolism can occur in brain ...
Previous research has described distinct subtypes of Alzheimer's disease (AD) based on the differenc...
PET studies have demonstrated bilateral temporo-parietal hypoperfusion and hypometabolism in probabl...
Posterior cortical hypometabolism measured with [ 18 F]-Fluorodeoxyglucose (FDG)-PET is a well-known...
ObjectiveUsing data from the Alzheimer's Disease Neuroimaging Initiative (ADNI) population, we exami...
Alzheimer’s Disease Neuroimaging Initiative.[Background] Previous research has described distinct su...
Background: We previously found temporoparietal-predominant atrophy patterns in the behavioral varia...
Background: We previously found temporoparietal-predominant atrophy patterns in the behavioral varia...
Understanding Alzheimer’s disease (AD) heterogeneity is important for understanding the underlying p...
Disentangling biologically distinct subgroups of Alzheimer's disease (AD) may facilitate a deeper un...
Disentangling biologically distinct subgroups of Alzheimer's disease (AD) may facilitate a deeper un...
Disentangling biologically distinct subgroups of Alzheimer’s disease (AD) may facilitate a deeper un...
Disentangling biologically distinct subgroups of Alzheimer’s disease (AD) may facilitate a deeper un...
Disentangling biologically distinct subgroups of Alzheimer's disease (AD) may facilitate a deeper un...
In PET studies of patients with Alzheimer disease (AD), prominent hypometabolism can occur in brain ...
In PET studies of patients with Alzheimer disease (AD), prominent hypometabolism can occur in brain ...
Previous research has described distinct subtypes of Alzheimer's disease (AD) based on the differenc...
PET studies have demonstrated bilateral temporo-parietal hypoperfusion and hypometabolism in probabl...
Posterior cortical hypometabolism measured with [ 18 F]-Fluorodeoxyglucose (FDG)-PET is a well-known...
ObjectiveUsing data from the Alzheimer's Disease Neuroimaging Initiative (ADNI) population, we exami...
Alzheimer’s Disease Neuroimaging Initiative.[Background] Previous research has described distinct su...
Background: We previously found temporoparietal-predominant atrophy patterns in the behavioral varia...
Background: We previously found temporoparietal-predominant atrophy patterns in the behavioral varia...
Understanding Alzheimer’s disease (AD) heterogeneity is important for understanding the underlying p...